Asthma Outcomes Following Early Versus Delayed Sinus Surgery in Chronic Rhinosinusitis With Nasal Polyps
- 30 December 2025
- journal article
- Published by Wiley in International Forum of Allergy & Rhinology
- Vol. 16 (5) , 477-483
Abstract
Background: Chronic rhinosinusitis with nasal polyps (CRSwNP) often coexists with asthma. Endoscopic sinus surgery (ESS) improves asthma morbidity, but the impact of early surgery (< 6 months from diagnosis) versus later surgery (1–3 years) is unclear. We examined whether early ESS is associated with improved asthma outcomes compared with delayed surgery. Methods: We conducted a retrospective cohort study using the TriNetX Research Network, including adults with CRSwNP who underwent ESS. Patients were grouped as early surgery (≤ 6 months after diagnosis) or late surgery (1–3 years). Outcomes over 5 years included asthma diagnoses by severity, exacerbations, and medication use (long‐acting β2‐agonists [LABA], corticosteroids, biologics). Propensity score matching was performed 1:1 ( N = 3683 per group) based on demographics, baseline asthma severity, and asthma medication usage. Results: After matching, groups were well balanced. Early ESS was associated with lower risk of moderate (11.5% vs. 13.5%; odds ratio [OR] = 0.84; p = 0.012) and severe persistent asthma (6.5% vs. 8.4%; OR = 0.76; p = 0.003). Rates of mild intermittent or persistent asthma and overall new asthma diagnoses did not differ. Early surgery patients had fewer associated asthma exacerbations (6.4% vs. 8.1%; OR = 0.78; p = 0.005) and were less likely to require LABAs (23.7% vs. 29.4%; OR = 0.75; p < 0.0001), steroids (63.7% vs. 67.4%; OR = 0.85; p = 0.0009), and biologics (7.7% vs. 10.1%; OR = 0.74; p = 0.0004). Conclusion: Early ESS for CRSwNP is associated with reduced progression to moderate/severe asthma, fewer exacerbations, and lower reliance on oral steroids, LABAs, and biologics. These findings suggest early surgery may alter asthma trajectory and reduce treatment burden in CRSwNP patients.Keywords
This publication has 24 references indexed in Scilit:
- Real‐World Evaluation of Asthma Severity Following Endoscopic Sinus Surgery in Chronic Rhinosinusitis PatientsOTO Open, 2024
- New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposisClinical Science, 2023
- Management paradigms for chronic rhinosinusitis in individuals with asthma: An evidence‐based review with recommendationsInternational Forum of Allergy & Rhinology, 2023
- Systemic Corticosteroid–related Adverse Outcomes and Health Care Resource Utilization and Costs Among Patients with Chronic Rhinosinusitis with Nasal PolyposisClinical Therapeutics, 2022
- Chronic Rhinosinusitis with Nasal Polyps and AsthmaThe Journal of Allergy and Clinical Immunology: In Practice, 2021
- Reevaluation of Diagnosis in Adults With Physician-Diagnosed AsthmaJAMA, 2017
- Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trialsThe Lancet Respiratory Medicine, 2015
- A comparison of 12 algorithms for matching on the propensity scoreStatistics in Medicine, 2013
- A systematic review and meta‐analysis of asthma outcomes following endoscopic sinus surgery for chronic rhinosinusitisInternational Forum of Allergy & Rhinology, 2013
- Long‐term impact of functional endoscopic sinus surgery on asthmaOtolaryngology–Head and Neck Surgery, 1999